“We’re one of the only institutions in the world that has accomplished the dual-purpose of using genetic information to accelerate scientific discovery in research while providing actionable clinical results to patients that can lead to preventative measures for diseases or inform on potential medication reactions,” said the paper’s senior author Chris Gignoux, PhD, MS, professor of Biomedical Informatics at CU Anschutz and the Director of Research for CCPM.
